Researcher
Karin Haustermans
- Disciplines:Radiation therapy, Cancer diagnosis, Cancer therapy, Cancer epidemiology
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Responsible
From1 Jan 2012 → Today - Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2005 → Today
Infrastructure
1 - 1 of 1
- The PaRtiCLE proton center. (Consortium coordinator)
Projects
1 - 10 of 40
- Outcome modeling in Proton TherapyFrom5 Apr 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Towards cost-effective patient selection for proton therapy in thoracic cancers: a framework for continuously updating prediction modelsFrom1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Real-time qPCR platform enhancing research activities within the Laboratory of Experimental Oncology and the Laboratory of Experimental RadiotherapyFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Implementation, optimisation and evaluation of proton therapy in esophageal cancerFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Proton versus Photon Therapy for Esophageal Cancer - a Trimodality StrategyFrom1 Jul 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- The importance of the TNM Classification for Cancer Surveillance.From20 Oct 2020 → 30 Apr 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Accurate patient-individual prediction of proton therapy benefit in thoracic cancers using 3D dose maps and radiomicsFrom1 Oct 2020 → 30 Sep 2023Funding: FWO junior postdoctoral fellowship
- Characterization of the biological benefits of ultra-high dose rate FLASH proton therapy.From31 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Organ preserving strategies in rectal cancerFrom10 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimization of overall treatment time for whole gland stereotactic body radiotherapy with integrated focal boosting in prostate cancerFrom6 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
41 - 50 of 365
- International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer(2021)
Authors: Karin Haustermans
Pages: 805 - 816 - ESTRO ACROP guidelines for the delineation of lymph nodal areas in upper gastrointestinal malignancies(2021)
Authors: Karin Haustermans
Pages: 92 - 97 - Radiation Dose Escalation for Early Prostate Cancer: Reigniting the FLAME? Reply(2021)
Authors: Karin Haustermans
Pages: 3086 - + - Automated treatment planning of prostate stereotactic body radiotherapy with focal boosting on a fast-rotating O-ring linac: Plan quality comparison with C-arm linacs(2021)
Authors: Robin De Roover, Wouter Crijns, Cédric Draulans, Karin Haustermans, Tom Depuydt
- Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial(2021)
Authors: Karin Haustermans, Sofie Isebaert, Cédric Draulans, Tom Depuydt
Pages: 98 - 104 - A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy(2021)
Authors: Cédric Draulans, Eric Van Cutsem, Gert De Meerleer, Sabine Tejpar, Jeroen Dekervel, Karin Haustermans
Pages: 1121 - 1125 - Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity(2021)
Authors: Maarten Lambrecht, Karin Haustermans
Pages: 241 - 248 - Ga-68-PSMA-11 PET, F-18-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability(2021)
Authors: Cédric Draulans, Raymond Oyen, Sofie Isebaert, Frederik Maes, Steven Joniau, Robin De Roover, Gilles Defraene, Karolien Goffin, Karin Haustermans
Pages: 202 - 211 - Parameters predicting [F-18]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer(2021)
Authors: Niloefar Ahmadi Bidakhvidi, Annouschka Laenen, Christophe Deroose, Koen Van Laere, Charlien Berghen, Gert De Meerleer, Karin Haustermans, Steven Joniau, Wouter Everaerts, Karolien Goffin
- Optimal68Ga-PSMA and18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer(2021)
Authors: Cédric Draulans, Robin De Roover, Sofie Isebaert, Frederik Maes, Raymond Oyen, Steven Joniau, Karolien Goffin, Karin Haustermans
Pages: 1211 - 1218